Inherited Cardiomyopathies

Callis, 2010, Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all, Expert Rev Mol Diagn, 10, 329, 10.1586/erm.10.13 Maron, 1996, Sudden death in young competitive athletes: clinical, demographic, and pathological profiles, JAMA, 276, 199, 10.1001/jama.1996.03540030033028 Seidman, 2011, Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history, Circ Res, 108, 743, 10.1161/CIRCRESAHA.110.223834 Ackerman, 2011, HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA), Heart Rhythm, 8, 1308, 10.1016/j.hrthm.2011.05.020 Hershberger, 2009, Genetic evaluation of cardiomyopathy: a Heart Failure Society of America practice guideline, J Card Fail, 15, 83, 10.1016/j.cardfail.2009.01.006 Maron, 1995, Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA Study, Circulation, 92, 785, 10.1161/01.CIR.92.4.785 Zou, 2004, Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults, Am J Med, 116, 14, 10.1016/j.amjmed.2003.05.009 Maron, 2003, Clinical course of hypertrophic cardiomyopathy with survival to advanced age, J Am Coll Cardiol, 42, 882, 10.1016/S0735-1097(03)00855-6 Cirino AL and Ho C: Familial Hypertrophic Cardiomyopathy Overview. In GeneReviews [Internet]. Copyright University of Washington, Seattle. 1993–2012. Available at http://www.ncbi.nlm.nih.gov/books/NBK1768, last revised May 17, 2011 Maron, 1979, Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy, Circulation, 59, 689, 10.1161/01.CIR.59.4.689 Maron, 2002, Hypertrophic cardiomyopathy: a systematic review, JAMA, 287, 1308, 10.1001/jama.287.10.1308 Fatkin, 2002, Molecular mechanisms of inherited cardiomyopathies, Physiol Rev, 82, 945, 10.1152/physrev.00012.2002 Teekakirikul, 2010, Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β, J Clin Invest, 120, 3520, 10.1172/JCI42028 Arad, 2005, Glycogen storage diseases presenting as hypertrophic cardiomyopathy, N Engl J Med, 352, 362, 10.1056/NEJMoa033349 Sachdev, 2002, Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy, Circulation, 105, 1407, 10.1161/01.CIR.0000012626.81324.38 Nishikawa, 1996, Hypertrophic cardiomyopathy in Noonan syndrome, Acta Paediatr Jpn, 38, 91, 10.1111/j.1442-200X.1996.tb03445.x Osterziel, 2002, Cardiac hypertrophy in Friedreich’s ataxia, Cardiovasc Res, 54, 694, 10.1016/S0008-6363(02)00333-4 Andersen, 2004, Genetic and phenotypic characterization of mutations in myosin-binding protein C (MYBPC3) in 81 families with familial hypertrophic cardiomyopathy: total or partial haploinsufficiency, Eur J Hum Genet, 12, 673, 10.1038/sj.ejhg.5201190 Ho, 2010, Genetics and clinical destiny: improving care in hypertrophic cardiomyopathy, Circulation, 122, 2430, 10.1161/CIRCULATIONAHA.110.978924 Geier, 2008, Beyond the sarcomere: cSRP3 mutations cause hypertrophic cardiomyopathy, Hum Mol Genet, 17, 2753, 10.1093/hmg/ddn160 Dhandapany, 2009, A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia, Nat Genet, 41, 187, 10.1038/ng.309 Watkins, 1995, Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy, N Engl J Med, 332, 1058, 10.1056/NEJM199504203321603 Ho, 2010, Hypertrophic cardiomyopathy, Heart Fail Clin, 6, 141, 10.1016/j.hfc.2009.12.001 Niimura, 2002, Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly, Circulation, 105, 446, 10.1161/hc0402.102990 Morita, 2008, Shared genetic causes of cardiac hypertrophy in children and adults, N Engl J Med, 358, 1899, 10.1056/NEJMoa075463 Wheeler, 2009, A new era in clinical genetic testing for hypertrophic cardiomyopathy, J Cardiovasc Transl Res, 2, 381, 10.1007/s12265-009-9139-0 Rozenfeld, 2011, Treatment of fabry disease: current and emerging strategies, Curr Pharm Biotechnol, 12, 916, 10.2174/138920111795542705 Semsarian, 2002, The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model, J Clin Invest, 109, 1013, 10.1172/JCI200214677 Hershberger RE, Kushner JD, and Parks SB: Dilated Cardiomyopathy Overview. In GeneReviews [Internet]. Copyright University of Washington, Seattle. 1993–2012. Available at http://www.ncbi.nlm.nih.gov/books/NBK1309, last revised March 19, 2009 Dec, 1994, Idiopathic dilated cardiomyopathy, N Engl J Med, 331, 1564, 10.1056/NEJM199412083312307 Schonberger, 2001, Many roads lead to a broken heart: the genetics of dilated cardiomyopathy, Am J Hum Genet, 69, 249, 10.1086/321978 van Spaendonck-Zwarts, 2010, Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy, Circulation, 121, 2169, 10.1161/CIRCULATIONAHA.109.929646 Morita, 2005, Genetic causes of human heart failure, J Clin Invest, 115, 518, 10.1172/JCI24351 Watkins, 2011, Inherited cardiomyopathies, N Engl J Med, 364, 1643, 10.1056/NEJMra0902923 Hershberger, 2010, Coding sequence rare variants identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 from 312 patients with familial or idiopathic dilated cardiomyopathy, Circ Cardiovasc Genet, 3, 155, 10.1161/CIRCGENETICS.109.912345 Hershberger, 2008, Coding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 patients with familial or idiopathic dilated cardiomyopathy, Clin Transl Sci, 1, 21, 10.1111/j.1752-8062.2008.00017.x Lakdawala, 2012, Genetic testing for dilated cardiomyopathy in clinical practice, J Card Fail, 18, 296, 10.1016/j.cardfail.2012.01.013 Zimmerman, 2010, A novel custom resequencing array for dilated cardiomyopathy, Genet Med, 12, 268, 10.1097/GIM.0b013e3181d6f7c0 Parks, 2008, Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy, Am Heart J, 156, 161, 10.1016/j.ahj.2008.01.026 van Tintelen, 2007, High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics, Am Heart J, 154, 1130, 10.1016/j.ahj.2007.07.038 Hong, 2005, Cardiac dysrhythmias, cardiomyopathy and muscular dystrophy in patients with Emery-Dreifuss muscular dystrophy and limb-girdle muscular dystrophy type 1B, J Korean Med Sci, 20, 283, 10.3346/jkms.2005.20.2.283 Elliott, 2010, Prevalence of desmosomal protein gene mutations in patients with dilated cardiomyopathy, Circ Cardiovasc Genet, 3, 314, 10.1161/CIRCGENETICS.110.937805 Garcia-Pavia, 2011, Desmosomal protein gene mutations in patients with idiopathic dilated cardiomyopathy undergoing cardiac transplantation: a clinicopathological study, Heart, 97, 1744, 10.1136/hrt.2011.227967 Herman, 2012, Truncations of titin causing dilated cardiomyopathy, N Engl J Med, 366, 619, 10.1056/NEJMoa1110186 Colucci, 2007, Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial, Circulation, 116, 49, 10.1161/CIRCULATIONAHA.106.666016 Corrado, 1997, Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study, J Am Coll Cardiol, 30, 1512, 10.1016/S0735-1097(97)00332-X Sen-Chowdhry, 2008, Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity, J Am Coll Cardiol, 52, 2175, 10.1016/j.jacc.2008.09.019 Corrado, 2009, Arrhythmogenic right ventricular cardiomyopathy: an update, Heart, 95, 766, 10.1136/hrt.2008.149823 Bauce, 2008, Comparison of clinical features of arrhythmogenic right ventricular cardiomyopathy in men versus women, Am J Cardiol, 102, 1252, 10.1016/j.amjcard.2008.06.054 Marcus, 2010, Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria, Eur Heart J, 31, 806, 10.1093/eurheartj/ehq025 Lombardi, 2011, Molecular genetics and pathogenesis of arrhythmogenic right ventricular cardiomyopathy: a disease of cardiac stem cells, Pediatr Cardiol, 32, 360, 10.1007/s00246-011-9890-2 den Haan, 2009, Comprehensive desmosome mutation analysis in North Americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy, Circ Cardiovasc Genet, 2, 428, 10.1161/CIRCGENETICS.109.858217 Protonotarios, 2004, Naxos disease and Carvajal syndrome: cardiocutaneous disorders that highlight the pathogenesis and broaden the spectrum of arrhythmogenic right ventricular cardiomyopathy, Cardiovasc Pathol, 13, 185, 10.1016/j.carpath.2004.03.609 Merner, 2008, Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene, Am J Hum Genet, 82, 809, 10.1016/j.ajhg.2008.01.010 Taylor, 2011, Genetic variation in titin in arrhythmogenic right ventricular cardiomyopathy-overlap syndromes, Circulation, 124, 876, 10.1161/CIRCULATIONAHA.110.005405 Beffagna, 2005, Regulatory mutations in transforming growth factor-β3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1, Cardiovasc Res, 65, 366, 10.1016/j.cardiores.2004.10.005 Tiso, 2001, Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2), Hum Mol Genet, 10, 189, 10.1093/hmg/10.3.189 Oechslin, 2011, Left ventricular non-compaction revisited: a distinct phenotype with genetic heterogeneity?, Eur Heart J, 32, 1446, 10.1093/eurheartj/ehq508 Tang, 2010, Left ventricular noncompaction is associated with mutations in the mitochondrial genome, Mitochondrion, 10, 350, 10.1016/j.mito.2010.02.003 Pignatelli, 2003, Clinical characterization of left ventricular noncompaction in children: a relatively common form of cardiomyopathy, Circulation, 108, 2672, 10.1161/01.CIR.0000100664.10777.B8 Ritter, 1997, Isolated noncompaction of the myocardium in adults, Mayo Clin Proc, 72, 26, 10.4065/72.1.26 Weiford, 2004, Noncompaction of the ventricular myocardium, Circulation, 109, 2965, 10.1161/01.CIR.0000132478.60674.D0 Richardson, 1996, Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies, Circulation, 93, 841, 10.1161/01.CIR.93.5.841 Elliott, 2008, Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases, Eur Heart J, 29, 270, 10.1093/eurheartj/ehm342 Maron, 2006, Circulation, 113, 1807, 10.1161/CIRCULATIONAHA.106.174287 Finsterer, 2009, Cardiogenetics, neurogenetics, and pathogenetics of left ventricular hypertrabeculation/noncompaction, Pediatr Cardiol, 30, 659, 10.1007/s00246-008-9359-0 Hoedemaekers, 2007, Cardiac β-myosin heavy chain defects in two families with non-compaction cardiomyopathy: linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies, Eur Heart J, 28, 2732, 10.1093/eurheartj/ehm429 Klaassen, 2008, Mutations in sarcomere protein genes in left ventricular noncompaction, Circulation, 117, 2893, 10.1161/CIRCULATIONAHA.107.746164 Vatta, 2003, Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction, J Am Coll Cardiol, 42, 2014, 10.1016/j.jacc.2003.10.021 Xing, 2006, Genetic analysis in patients with left ventricular noncompaction and evidence for genetic heterogeneity, Mol Genet Metab, 88, 71, 10.1016/j.ymgme.2005.11.009 Hermida-Prieto, 2004, Familial dilated cardiomyopathy and isolated left ventricular noncompaction associated with lamin A/C gene mutations, Am J Cardiol, 94, 50, 10.1016/j.amjcard.2004.03.029 Ichida, 2001, Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome, Circulation, 103, 1256, 10.1161/01.CIR.103.9.1256 Ichida, 2009, Left ventricular noncompaction, Circ J, 73, 19, 10.1253/circj.CJ-08-0995 Pauli, 1999, Ventricular noncompaction and distal chromosome 5q deletion, Am J Med Genet, 85, 419, 10.1002/(SICI)1096-8628(19990806)85:4<419::AID-AJMG21>3.0.CO;2-S Sen-Chowdhry, 2010, Genetics of restrictive cardiomyopathy, Heart Fail Clin, 6, 179, 10.1016/j.hfc.2009.11.005 Karam, 2008, A de novo mutation of the beta cardiac myosin heavy chain gene in an infantile restrictive cardiomyopathy, Congenit Heart Dis, 3, 138, 10.1111/j.1747-0803.2008.00165.x Kubo, 2007, Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype, J Am Coll Cardiol, 49, 2419, 10.1016/j.jacc.2007.02.061 Kaski, 2008, Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes, Heart, 94, 1478, 10.1136/hrt.2007.134684 Mogensen, 2003, Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations, J Clin Invest, 111, 209, 10.1172/JCI200316336 Peddy, 2006, Infantile restrictive cardiomyopathy resulting from a mutation in the cardiac troponin T gene, Pediatrics, 117, 1830, 10.1542/peds.2005-2301 Arbustini, 2006, Desmin accumulation restrictive cardiomyopathy and atrioventricular block associated with desmin gene defects, Eur J Heart Fail, 8, 477, 10.1016/j.ejheart.2005.11.003 Biagini, 2005, Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients, J Am Coll Cardiol, 46, 1543, 10.1016/j.jacc.2005.04.062 Bos, 2006, Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin, Mol Genet Metab, 88, 78, 10.1016/j.ymgme.2005.10.008 Zhang, 2011, Desmosomal protein gene mutations in patients with idiopathic DCM, Heart, 97, 2090, 10.1136/heartjnl-2011-301043 Klauke, 2010, De novo desmin-mutation N116S is associated with arrhythmogenic right ventricular cardiomyopathy, Hum Mol Genet, 19, 4595, 10.1093/hmg/ddq387 Otten, 2010, Desmin mutations as a cause of right ventricular heart failure affect the intercalated disks, Heart Rhythm, 7, 1058, 10.1016/j.hrthm.2010.04.023 van Tintelen, 2009, Severe cardiac phenotype with right ventricular predominance in a large cohort of patients with a single missense mutation in the DES gene, Heart Rhythm, 6, 1574, 10.1016/j.hrthm.2009.07.041 Moller, 2009, The role of sarcomere gene mutations in patients with idiopathic dilated cardiomyopathy, Eur J Hum Genet, 17, 1241, 10.1038/ejhg.2009.34 Mirza, 2007, The effect of mutations in α-tropomyosin (E40K and E54K) that cause familial dilated cardiomyopathy on the regulatory mechanism of cardiac muscle thin filaments, J Biol Chem, 282, 13487, 10.1074/jbc.M701071200 Morimoto, 2002, Ca(2+)-desensitizing effect of a deletion mutation Delta K210 in cardiac troponin T that causes familial dilated cardiomyopathy, Proc Natl Acad Sci U S A, 99, 913, 10.1073/pnas.022628899 Robinson, 2007, Dilated and hypertrophic cardiomyopathy mutations in troponin and α-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments, Circ Res, 101, 1266, 10.1161/CIRCRESAHA.107.156380 Venkatraman, 2003, Different functional properties of troponin T mutants that cause dilated cardiomyopathy, J Biol Chem, 278, 41670, 10.1074/jbc.M302148200 Ashrafian, 2007, Reviews of translational medicine and genomics in cardiovascular disease: new disease taxonomy and therapeutic implications cardiomyopathies: therapeutics based on molecular phenotype, J Am Coll Cardiol, 49, 1251, 10.1016/j.jacc.2006.10.073 Norton, 2012, Evaluating pathogenicity of rare variants from dilated cardiomyopathy in the exome era, Circ Cardiovasc Genet, 5, 167, 10.1161/CIRCGENETICS.111.961805 Van Driest, 2004, Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy, J Am Coll Cardiol, 44, 1903, 10.1016/j.jacc.2004.07.045 Alders, 2003, The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands, Eur Heart J, 24, 1848, 10.1016/S0195-668X(03)00466-4 Need, 2012, Clinical application of exome sequencing in undiagnosed genetic conditions, J Med Genet, 49, 353, 10.1136/jmedgenet-2012-100819 Ionita-Laza, 2009, Estimating the number of unseen variants in the human genome, Proc Natl Acad Sci U S A, 106, 5008, 10.1073/pnas.0807815106 Aatre, 2011, Psychological issues in genetic testing for inherited cardiovascular diseases, Circ Cardiovasc Genet, 4, 81, 10.1161/CIRCGENETICS.110.957365